# Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

Study · id `cardio:ct-nct05662462` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05662462](<https://clinicaltrials.gov/study/NCT05662462>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05662462

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 124 participants.

## Technical summary

Registry record NCT05662462. Randomized; single masking; primary purpose treatment. Start 2024-07-11 (actual); primary completion 2028-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 124 participants (planned count; ClinicalTrials.gov record NCT05662462, source copy `cardio:ctgov-nct05662462-2026-06-29`, retrieved 2026-10-26)
- Started: 2024-07-11 (actual) (ClinicalTrials.gov record NCT05662462, source copy `cardio:ctgov-nct05662462-2026-06-29`, retrieved 2026-10-26)
- Primary completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT05662462, source copy `cardio:ctgov-nct05662462-2026-06-29`, retrieved 2026-10-26)
- Completion: 2029-03 (anticipated) (ClinicalTrials.gov record NCT05662462, source copy `cardio:ctgov-nct05662462-2026-06-29`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05662462, source copy `cardio:ctgov-nct05662462-2026-06-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05662462-2026-06-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
- Condition: Pre-Gestational Diabetes
- Condition: Type2diabetes
- Condition: Pregnancy in Diabetic
- Condition: Pregnancy, High Risk
- Intervention (Device): DEXCOM G7 PRO Continuous Glucose Monitor
- Intervention (Device): Patient mHealth app linked to a provider dashboard
- Intervention (Behavioral): Care team coaching for medical and social needs (HUB)
- Intervention (Device): Provider dashboard
- Lead sponsor: Ohio State University
- Lead sponsor class: OTHER
- Collaborator: Agency for Healthcare Research and Quality (AHRQ)
- Collaborator class: FED
- Collaborator: DexCom, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Ohio State University (`cardio:org-ohio-state-university`)
- Registry lists this organization as a collaborator: Agency for Healthcare Research and Quality (`core:ahrq`)
- Registry lists this organization as a collaborator: DexCom, Inc. (`cardio:org-dexcom-inc`)

## Provenance

Content hash: 6a8aa11b697a1e67239e173aa9f55e6003264bfbe4a29d241396e2a1090770e4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
